MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MEDITE Cancer Diagnostics Inc (MDIT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7123
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company’s products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. MEDITE is headquartered in Orlando, Florida, the US.

MEDITE Cancer Diagnostics Inc (MDIT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
MEDITE Cancer Diagnostics Raises USD0.9 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD1.2 Million in Venture Financing 11
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 12
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 13
Partnerships 14
Medite To Enter Into Licensing Agreement With Unic Technologies 14
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 15
Equity Offering 16
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 16
Debt Offering 17
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 17
Acquisition 18
CytoCore Completes Acquisition Of Medite 18
MEDITE Cancer Diagnostics Inc – Key Competitors 19
MEDITE Cancer Diagnostics Inc – Key Employees 20
MEDITE Cancer Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 22
Corporate Communications 24
Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director 24
Nov 08, 2017: MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer 25
Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer 26
Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors 27
Product News 28
Jul 27, 2017: MEDITE Cancer Diagnostics to Launch SureCyte C1 Stain Globally at the 29th European Congress of Pathology 28
Other Significant Developments 29
May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 29
Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
MEDITE Cancer Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MEDITE Cancer Diagnostics Raises USD0.9 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD1.2 Million in Venture Financing 11
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 12
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 13
Medite To Enter Into Licensing Agreement With Unic Technologies 14
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 15
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 16
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 17
CytoCore Completes Acquisition Of Medite 18
MEDITE Cancer Diagnostics Inc, Key Competitors 19
MEDITE Cancer Diagnostics Inc, Key Employees 20
MEDITE Cancer Diagnostics Inc, Subsidiaries 21

List of Figures
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Its artificial heart products consist of an implantable heart. Carmat offers components …
  • Cogeco Communications Inc (CCA):企業の財務・戦略的SWOT分析
    Cogeco Communications Inc (CCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Jazeera Airways Company KSC:企業の戦略・SWOT・財務情報
    Jazeera Airways Company KSC - Strategy, SWOT and Corporate Finance Report Summary Jazeera Airways Company KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Everbright Limited (165):企業の財務・戦略的SWOT分析
    China Everbright Limited (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Uscom Ltd (UCM):企業の製品パイプライン分析
    Summary Uscom Ltd (Uscom) is a medical device company which focuses on the development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary monitoring technologies. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-inv …
  • Acciona SA:戦略・SWOT・企業財務分析
    Acciona SA - Strategy, SWOT and Corporate Finance Report Summary Acciona SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • Verona Pharma Plc (VRNA):企業の財務・戦略的SWOT分析
    Verona Pharma Plc (VRNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oil India Ltd (OIL):企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Carbon Energy Corp (CRBO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carbon Energy Corp (Carbon Energy), formerly Carbon Natural Gas Company is an independent oil and gas company. The company operates in the exploration, operation, management, and development of oil and gas properties in the Appalachian and Illinois Basin regions of the US. It holds interests …
  • NAPEC Inc. (NPC)-エネルギー分野:企業M&A・提携分析
    Summary NAPEC Inc. (NAPEC), formerly CVTech Group Inc., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company installs gas-powered and elect …
  • Phoenix Brands LLC:企業の戦略・SWOT・財務情報
    Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report Summary Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kangmei Pharmaceutical Co Ltd (600518):製薬・医療:M&Aディール及び事業提携情報
    Summary Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Kangmei products include Chinese herbal medicine, bottled single product, hong mei life, xinkaihe senate, chinese medicine derived, medici …
  • Morgan Advanced Materials plc (MGAM):企業の財務・戦略的SWOT分析
    Summary Morgan Advanced Materials Plc (Morgan) is a diversified company. The company designs, manufactures and markets technical ceramics, thermal ceramics, molten metal systems, electrical carbon, braze alloys, fire protection products, seals and bearings, specialty graphite, and composites and def …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Punj Lloyd Ltd (PUNJLLOYD):企業の財務・戦略的SWOT分析
    Punj Lloyd Ltd (PUNJLLOYD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • China International Travel Service Corporation Limited:企業の戦略・SWOT・財務分析
    China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆